Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Am J Obstet Gynecol. 2009 Jan 24;200(4):392.e1–392.10. doi: 10.1016/j.ajog.2008.10.033

Table 3. Angiogenic Factor Concentrations at 10-20, 21-32, and 33-42 Weeks of Gestation in Normotensive Controls and in Women Who Subsequently Developed Proteinuria Documented either by Dipstick or by 24-hour Urine or Protein/Creatinine Ratio.

10-20 wks Control GP by Dipstick GP by 24 Hr Urine or P/C Ratio
N 1353 79 19
GA at collection (days) 114 ± 19 113 ± 19 116 ± 21
sFlt-1 (pg/ml) 3786 ± 1989 3368 ± 1814 3636 ± 2074
PlGF (pg/ml) 146 ± 126 115 ± 72* 163 ± 151
sEng (ng/ml) 5.6 ± 5.4 5.0 ± 1.0 5.30 ± 1.13
21-32 wks
N 1363 65 15
GA at collection (days) 192 ± 11 194 ± 11 194 ± 11
sFlt-1 (pg/ml) 4005 ± 2356 3769 ± 2078 4391 ± 2901
PlGF (pg/ml) 733 ± 621 591 ± 455 496 ± 198
sEng (ng/ml) 5.5 ± 7.6 5.3 ± 2.1 5.5 ± 1.5
33-42 wks
N 1217 43 6
GA at collection (days) 255 ± 6 257 ± 9 256 ± 7
sFlt-1 (pg/ml) 7823 ± 4725 9450 ± 6086* 10108 ± 3524*
PlGF (pg/ml) 583 ± 697 384 ± 436* 170 ± 66*
sEng (ng/ml) 10.2 ± 7.9 11.8 ± 8.7 15.2 ± 6.6**

Data is presented as N for number of specimens or arithmetic mean ± s.d.

GA = gestational age GP = gestational proteinuria

sFlt-1 = soluble fms-like tyrosine kinase 1 PlGF = placental growth factor sEng = soluble endoglin

Comparisons of angiogenic factor concentrations used logarithmically transformed values.

*

P <0.05,

**

P <0.01

***

P < 0.001 for comparisons with controls after adjusting for BMI, race/ethnicity, and GA at collection

There were no significant differences in angiogenic factor concentrations between GP by dipstick and GP by 24-hour urine or P/C ratio